Cell
therapy is one of the most promising healthcare procedure for
restoration of damaged tissue. Cell therapies have huge potential for
the wide range of disease treatment including tissue degradation,
immune deficiency, metabolic disorders, and cancer. Cell therapy are
categorized into two type’s allogeneic (cells from third party
donor) and autologous (cells from one’s own body). Cell therapy has
gained significant traction in recent past and currently it under
commercial development. Main objective of cell therapy is to
re-establish the lost function of tissues and cells rather than to
produce a new organ. Some cell therapies have been established and
permitted for clinical trial. For instance, in 2013 a stage 2
clinical trial was completed for transplantation of bone marrow
derived stem cells in affected knee by rheumatoid arthritis. The
growth of this technique is also increased due to involvement of the
government agencies. For instance, innovate U.K. 2014 report showed
that government agreed to fund US$15.3 million in cell therapy
manufacturing market.
Get
In-Depth Sample Copy of Research @
https://www.coherentmarketinsights.com/insight/request-sample/1728
Cell
Therapy Manufacturing Market Dynamics
Increasing
number of surgical procedures performed across the world coupled with
increasing number of trauma and accidents is propelling demand for
new medical therapy. For instance, according to a 2015, World Health
Organization (WHO) report, more than 50,000 stem cell transplants are
carried out annually worldwide for various surgeries. Stem cells
transplantation is promising medical therapy for patients with
advance stage diseases like Alzheimer’s, arthritis, autism,
blindness, cancer, cerebral palsy, diabetes etc. Key
biopharmaceutical companies are majorly investing in research for
cell therapy. For instance, Longeveron LL, a biopharmaceutical
company received a US$ 750,000 grant from the Maryland Technology
Development Corporation (TEDCO) in 2018 for stem cell therapy
research. These collaborations and government funding are boosting
growth of the cell therapy manufacturing market. However, the strict
regulations, guidelines, and various health safety concerns over cell
therapy treatment are restraining growth of the cell therapy market.
Cell
Therapy Manufacturing Market - Regional Insights
On
the basis of the region, the global cell therapy market is segmented
into North America, Latin America, Europe, Asia Pacific, Middle East,
and Africa. North America holds the dominant position in the global
cell therapy manufacturing market, owing to large number of surgeries
performed in the region as well as development of technologically
advanced products for therapy. According to the National Health
Statistics Report by the Centers for Disease Control & Prevention
(CDC), around 201,748.3 million surgical and non-surgical procedures
were performed in the U.S. in 2011.
Cell
Therapy Manufacturing Market - Competitive Insights
The
key player operating in the global cell therapy manufacturing market
include,
Pharmicell,
Merck Group, Dickinson and Company, Thermo Fisher, Lonza Group,
Miltenyi Biotec GmBH, Takara Bio Group, STEMCELL Technologies,
Cellular Dynamics International, Becton, Osiris Therapeutics, Bio-Rad
Laboratories, Inc., Anterogen, MEDIPOST, Holostem Terapie Avanazate,
Pluristem Therapeutics, Brammer Bio, CELLforCURE, Gene Therapy
Catapult EUFETS, MaSTherCell, PharmaCell, Cognate BioServices and
WuXi AppTec. Key players are adoption growth strategies such as
collaborations, introduction of new technologies and devices to
maintain dominant position in the market. For instance, in 2014,
ViaCyte, Inc. successfully implanted VC-01 an embryonic stem cell
derived islet for the treatment of type 1 diabetes.
Cell
Therapy Manufacturing Market Taxonomy:
On
the basis of therapy type, the global cell therapy manufacturing
market is segmented into:
-
Allogeneic Cell Therapy
-
Autologous Cell Therapy
On
the basis of Technology:
-
Somatic Cell Technology
-
Cell Immortalization Technology
-
Viral Vector Technology
-
Genome Editing Technology
-
Cell Plasticity Technology
-
3D Technology
For
More Details About This Exclusive Research, Talk to Our Analyst @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1728
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment